A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in australia.
Surabhi S LiyanageEva SegelovAisha MalikSuzanne M GarlandSepehr N TabriziEleanor CumminsHolly SealeBayzidur RahmanAye M MoaAndrew P BarbourPhilip J CroweC Raina MacIntyrePublished in: Journal of oncology (2014)
Objective. We investigate the prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma (OSCC) tissues compared to oesophageal tissue from healthy controls, in an Australian cohort. Methods. We conducted a hospital-based case-control study of 99 patients with OSCC and 100 healthy controls to examine the presence of HPV DNA. Paraffin tissues were tested using the PapType high-risk HPV detection and genotyping kit and with INNO-LiPA HPV Genotyping Extra. The biopsy samples were tested for HPV using a PCR-ELISA method based on the L1 consensus primer set PGMY09-PGMY11. Results. HPV DNA of the oncogenic genotype 16 was detected in 1/99 case specimens, a rate of 1010 per 100,000 (95% CI: 30-5500). All control specimens were negative for HPV. Significantly higher rates of smoking, other aerodigestive cancers, and mortality were seen among cases than controls. A pooled analysis of this study and the only other Australian case-control study found that 9/321 cases and 0/155 controls were positive for HPV. The pooled odds ratio for HPV being a risk factor for OSCC was 9.35 (95% CI: 0.47-190.33). Conclusion. Our results suggest that in this multifactorial cancer HPV may be an additional risk factor; although a larger, better powered study is needed.
Keyphrases
- high grade
- squamous cell carcinoma
- cervical cancer screening
- risk factors
- gene expression
- clinical trial
- cardiovascular disease
- randomized controlled trial
- single molecule
- type diabetes
- radiation therapy
- high throughput
- transcription factor
- smoking cessation
- cardiovascular events
- cell free
- phase iii
- quantum dots
- nucleic acid
- circulating tumor cells